Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature

Melanoma and Skin Cancer

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Br J Dermatol.

Gault A, Anderson AE, Plummer R, Stewart C, Pratt AG, Rajan N

doi: 10.1111/bjd.19750.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin Cancer

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Melanoma Res.

Dudda M, Mann C, Heinz J, Schmidgen I, Weid F, Kühn M, Saloga J, Grabbe S, Loquai C

doi: 10.1097/CMR.0000000000000703.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin CancerImmunotherapy

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

J Clin Neuromuscul Dis.

Supakornnumporn S, Katirji B

doi: 10.1097/ CND.0000000000000193.

Melanoma and Skin Cancer

Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature

Melanoma Res.

Kosche C, Stout M, Sosman J, Lukas RV, Choi JN

doi: 10.1097/CMR.0000000000000642.

Melanoma and Skin Cancer

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Melanoma Res.

Thummalapalli R, Melms JC, Mier J, Izar B

doi: 10.1097/CMR.0000000000000646.

Melanoma and Skin CancerImmunotherapy

Myasthenia triggered by immune checkpoint inhibitors: New case and literature review

Neuromuscul Disord.

Gonzalez NL, Puwanant A, Lu A, Marks SM, Živković SA

doi: 10.1016/j.nmd.2017.01.002.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Acquired generalized lipodystrophy under immune checkpoint inhibition

Br J Dermatol.

Haddad N, Vidal-Trecan T, Baroudjian B, Zagdanski AM, Arangalage D, Battistella M, Gautier JF, Lebbe C, Delyon J, PATIO group

doi: 10.1111/bjd.18124.

Melanoma and Skin CancerImmunotherapy

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease

Br J Dermatol.

Weber J, Glutsch V, Geissinger E, Haug L, Lock JF, Schneider F, Kneitz H, Goebeler M, Schilling B, Gesierich A

doi: 10.1111/bjd.18739.

Melanoma and Skin Cancer

Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopy

Int J Dermatol.

Mazzella C, Costa C, Cappello M, Scalvenzi M

doi: 10.1111/ijd.14128.

Related content

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Myasthenia triggered by immune checkpoint inhibitors: New case and literature review

Acquired generalized lipodystrophy under immune checkpoint inhibition

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease

Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopy